Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Moran

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Oncologist|September 4, 2023
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or BothMarc P Bonaca, Javid J Moslehi, Jonathan A Ledermann, et al.
Health Facilities Management|January 29, 2009
Creating environment for cancer careDoug Abrams, Debra Bemis, Tom Gribbin, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 3, 2025
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaGilles Salles, Christopher P Fox, Mehdi Hamadani, et al.
Nature Chemical Biology|August 28, 2019
Extracellular phosphorylation drives the formation of neuronal circuitryHidekiyo Harada, Nahal Farhani, Xue-Fan Wang, et al.
Nucleic Acids Research|May 15, 2014
Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stressSimon S McDade, Daksha Patel, Michael Moran, et al.
Urologic Oncology|May 3, 2008
Phase I/II trial of docetaxel and concurrent radiation therapy in localized high risk prostate cancer (AGUSG 03-10)Michael Perrotti, Todd Doyle, Parvesh Kumar, et al.
Cancer Treatment Reviews|May 14, 2021
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancerJean Bourhis, Alexander Stein, Jan Paul de Boer, et al.
American Journal of Hematology|April 8, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-UpJennifer A Woyach, Relja Popovic, Emily L Rossi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern IrelandStephanie G Craig, Lesley A Anderson, Michael Moran, et al.
British Journal of Cancer|March 21, 2019
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approachStephanie G Craig, Lesley A Anderson, Andrew G Schache, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Oncologist|September 4, 2023
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or BothMarc P Bonaca, Javid J Moslehi, Jonathan A Ledermann, et al.
Health Facilities Management|January 29, 2009
Creating environment for cancer careDoug Abrams, Debra Bemis, Tom Gribbin, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 3, 2025
Indirect Comparison of Epcoritamab Versus Axicabtagene Ciloleucel in Chimeric Antigen Receptor T-Cell-Eligible and -Naive Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaGilles Salles, Christopher P Fox, Mehdi Hamadani, et al.
Nature Chemical Biology|August 28, 2019
Extracellular phosphorylation drives the formation of neuronal circuitryHidekiyo Harada, Nahal Farhani, Xue-Fan Wang, et al.
Nucleic Acids Research|May 15, 2014
Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stressSimon S McDade, Daksha Patel, Michael Moran, et al.
Urologic Oncology|May 3, 2008
Phase I/II trial of docetaxel and concurrent radiation therapy in localized high risk prostate cancer (AGUSG 03-10)Michael Perrotti, Todd Doyle, Parvesh Kumar, et al.
Cancer Treatment Reviews|May 14, 2021
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancerJean Bourhis, Alexander Stein, Jan Paul de Boer, et al.
American Journal of Hematology|April 8, 2026
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-UpJennifer A Woyach, Relja Popovic, Emily L Rossi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2019
Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern IrelandStephanie G Craig, Lesley A Anderson, Michael Moran, et al.
British Journal of Cancer|March 21, 2019
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approachStephanie G Craig, Lesley A Anderson, Andrew G Schache, et al.
Pageof 6